Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of SomaLogic, Inc. (NASDAQ: SLGC) to Standard BioTools Inc. for 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock is fair to SomaLogic shareholders.
Halper Sadeh encourages SomaLogic shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
The investigation concerns whether SomaLogic and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for SomaLogic shareholders; (2) determine whether Standard BioTools is underpaying for SomaLogic; and (3) disclose all material information necessary for SomaLogic shareholders to adequately assess and value the merger consideration. On behalf of SomaLogic shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh encourages SomaLogic shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231004419283/en/
